Exhibit 99.1
AdvanSix.com
News Release
ADVANSIX ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS
Sales of $479 million, up 7% versus prior year
Earnings Per Share of $0.35; Adjusted Earnings Per Share of $0.43
Cash Flow from Operations of $59 million, down 23% versus prior year
Returned $17 million of cash to shareholders through dividends and repurchases
Parsippany, N.J., November 4, 2022 - AdvanSix (NYSE: ASIX) today announced its financial results for the third quarter ending September 30, 2022. Overall, results were impacted by the previously announced extended planned plant turnaround.
Third Quarter 2022 Summary
•Sales up approximately 7% versus prior year driven by 18% favorable impact of market-based pricing, 4% higher raw material pass-through pricing, and 3% contribution from acquisitions, partially offset by 18% lower volume
•Net Income of $10.0 million, a decrease of $33.9 million versus the prior year
•Adjusted EBITDA of $33.3 million, a decrease of $44.4 million versus the prior year
•Cash Flow from Operations of $58.9 million, a decrease of $17.6 million versus the prior year
•Capital Expenditures of $22.2 million, an increase of $9.2 million versus the prior year
•Free Cash Flow of $36.7 million, a decrease of $26.8 million versus the prior year
•Repurchased 362,609 shares for approximately $13 million in 3Q22; Year-to-date repurchases of approximately $24 million
•Increased 3Q22 quarterly dividend by 16% to $0.145 per share
“Our third quarter performance reflects the resilience of our business model and our ability to navigate challenging conditions," said Erin Kane, president and CEO of AdvanSix. "Despite the unfavorable impact of the extended plant turnaround as previously announced on October 7, sales grew year-over-year as our commercial execution offset lower sales volume. Our healthy cash flow performance continued to support smart and disciplined deployment of capital in the quarter into reinvestment in the business, $17 million of cash returned to shareholders in the form of dividends and share repurchases, and further debt reduction."
1
Summary third quarter 2022 financial results for the Company are included below:
($ in Thousands, Except Earnings Per Share) | 3Q 2022 | 3Q 2021 | |||||||||
| Sales | $478,769 | $446,495 | |||||||||
| Net Income | 10,032 | 43,942 | |||||||||
| Diluted Earnings Per Share | $0.35 | $1.51 | |||||||||
Adjusted Diluted Earnings Per Share (1) | $0.43 | $1.58 | |||||||||
Adjusted EBITDA (1) | 33,313 | 77,687 | |||||||||
Adjusted EBITDA Margin % (1) | 7.0% | 17.4% | |||||||||
| Cash Flow from Operations | 58,934 | 76,488 | |||||||||
Free Cash Flow (1)(2) | 36,703 | 63,495 | |||||||||
(1) See “Non-GAAP Measures” included in this press release for non-GAAP reconciliations
(2) Net cash provided by operating activities less capital expenditures
Sales of $479 million in the quarter increased approximately 7% versus the prior year. Market-based pricing was favorable by 18% compared to the prior year driven by higher pricing across our ammonium sulfate and nylon product lines. Raw material pass-through pricing was favorable by 4% following a net cost increase in benzene and propylene (inputs to cumene which is a key feedstock to our products). The acquisition of U.S. Amines contributed approximately 3% to sales in the quarter. Sales volume decreased approximately 18% driven primarily by the unfavorable impact of the extended plant turnaround and lower production output overall compared to the prior year.
Sales by product line and approximate percentage of total sales are included below:
| ($ in Thousands) | 3Q 2022 | 3Q 2021 | |||||||||||||||||||||
| Sales | % of Total | Sales | % of Total | ||||||||||||||||||||
| Nylon | $ | 141,017 | 29% | $ | 122,110 | 27% | |||||||||||||||||
| Caprolactam | 90,818 | 19% | 80,265 | 18% | |||||||||||||||||||
| Chemical Intermediates | 115,268 | 24% | 130,920 | 29% | |||||||||||||||||||
| Ammonium Sulfate | 131,666 | 28% | 113,200 | 26% | |||||||||||||||||||
| $ | 478,769 | 100% | $ | 446,495 | 100% | ||||||||||||||||||
Adjusted EBITDA of $33.3 million in the quarter decreased $44.4 million versus the prior year primarily due to the unfavorable impact of the extended planned plant turnaround, lower sales volume, inflation, and higher utilities cost driven by natural gas prices, partially offset by higher market-based pricing, net of increased raw material costs.
Adjusted earnings per share of $0.43 decreased $1.15 versus the prior year driven primarily by the factors discussed above, partially offset by a lower effective tax rate in the quarter versus the prior year.
Cash flow from operations of $58.9 million in the quarter decreased $17.6 million versus the prior year
2
primarily due to lower net income, partially offset by the favorable impact of changes in working capital. Capital expenditures of $22.2 million in the quarter increased $9.2 million versus the prior year.
Dividend
The Company's Board of Directors declared a quarterly cash dividend of $0.145 per share on the Company's common stock. The dividend is payable on November 29, 2022 to stockholders of record as of the close of business on November 15, 2022.
Outlook
•4Q22 expected performance rebounding towards results demonstrated in 1Q22 and 2Q22 as well as continued strong cash flow generation
•Expect strong underlying agriculture and fertilizer industry fundamentals to continue
•North American demand for nylon and chemical intermediates mixed overall; softness in consumer durables and building and construction end markets
•Targeting our typical high plant utilization rates as supported by our global competitive position
•Capital Expenditures tracking to approximately $95 million for the full year 2022
•Expect pre-tax income impact of planned plant turnarounds to be $28 million to $33 million in 2023 versus approximately $50 million in 2022
"Our outlook is supported by our diverse product portfolio, advantage of our business model, and strong underlying agriculture and fertilizer industry fundamentals. The growth prospects of AdvanSix remain robust, and we are committed to delivering long-term value to our shareholders. We've demonstrated our ability to successfully perform through all market conditions and expand our earnings base while generating robust cash flow and look forward to closing out 2022 with another strong quarter,” concluded Kane.
Conference Call Information
AdvanSix will discuss its results during its investor conference call today starting at 9:00 a.m. ET. To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:00 a.m. ET start, and tell the operator that you are dialing in for AdvanSix’s third quarter 2022 earnings call. The live webcast of the investor call as well as related presentation materials can be accessed at http://investors.advansix.com. Investors can hear a replay of the conference call from 12 noon ET on November 4 until 12 noon ET on November 11 by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international). The access code is 3129770.
About AdvanSix
AdvanSix plays a critical role in global supply chains, innovating and delivering essential products for our customers in a wide variety of end markets and applications that touch people’s lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. Our reliable and sustainable supply of quality products emerges from the integrated value chain of our five U.S.-based manufacturing facilities. AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, chemical intermediates, and plant nutrients,
3
guided by our core values of Safety, Integrity, Accountability and Respect. More information on AdvanSix can be found at http://www.advansix.com.
Forward Looking Statements
This release contains certain statements that may be deemed “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements may be identified by words such as "expect," "anticipate," "estimate," “outlook,” "project," "strategy," "intend," "plan," "target," "goal," "may," "will," "should" and "believe" and other variations or similar terminology and expressions. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: general economic and financial conditions in the U.S. and globally, including the impact of the coronavirus (COVID-19) pandemic and any resurgences; the potential effects of inflationary pressures, labor market shortages and supply chain issues; instability or volatility in financial markets or other unfavorable economic or business conditions caused by geopolitical concerns, including as a result of the conflict between Russia and Ukraine; the scope, shape and pace of recovery of the pandemic including the impact of social and economic restrictions and other containment measures taken to combat virus transmission; the effect on our customers’ demand for our products and our suppliers’ ability to manufacture and deliver our raw materials, including implications of reduced refinery utilization in the U.S.; our ability to sell and provide our goods and services; the ability of our customers to pay for our products; any closures of our and our customers’ offices and facilities; risks associated with increased phishing, compromised business emails and other cybersecurity attacks and disruptions to our technology infrastructure; risks associated with employees working remotely or operating with a reduced workforce; risks associated with our indebtedness including compliance with financial and restrictive covenants, and our ability to access capital on reasonable terms, at a reasonable cost, or at all, due to economic conditions; the impact of scheduled turnarounds and significant unplanned downtime and interruptions of production or logistics operations as a result of mechanical issues or other unanticipated events such as fires, severe weather conditions, natural disasters, pandemics and geopolitical conflicts and related events; price fluctuations, cost increases and supply of raw materials; our operations and growth projects requiring substantial capital; growth rates and cyclicality of the industries we serve including global changes in supply and demand; failure to develop and commercialize new products or technologies; loss of significant customer relationships; adverse trade and tax policies; extensive environmental, health and safety laws that apply to our operations; hazards associated with chemical manufacturing, storage and transportation; litigation associated with chemical manufacturing and our business operations generally; inability to acquire and integrate businesses, assets, products or technologies; protection of our intellectual property and proprietary information; prolonged work stoppages as a result of labor difficulties or otherwise; cybersecurity, data privacy incidents and disruptions to our technology infrastructure; failure to maintain effective internal controls; our ability to declare and pay quarterly cash dividends and the amounts and timing of any future dividends; our ability to repurchase our common stock and the amount and timing of any future repurchases; disruptions in supply chain, transportation and logistics; potential for uncertainty regarding qualification for tax treatment of our spin-off; fluctuations in our stock price; and changes in laws or regulations applicable to our business. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by such forward-looking statements. We identify the principal risks and uncertainties that affect our performance in our filings with the Securities and Exchange Commission (SEC), including the risk factors in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021, as updated in subsequent reports filed with the SEC.
Non-GAAP Financial Measures
This press release includes certain non-GAAP financial measures intended to supplement, not to act as substitutes for, comparable GAAP measures. Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in this press release. Investors are urged to consider carefully the comparable GAAP measures and the reconciliations to those measures provided. Non-GAAP measures in this press release may be calculated in a way that is not comparable to similarly-titled measures reported by other companies.
# # #
| Contacts: | |||||
| Media | Investors | ||||
| Janeen Lawlor | Adam Kressel | ||||
| (973) 526-1615 | (973) 526-1700 | ||||
| janeen.lawlor@advansix.com | adam.kressel@advansix.com | ||||
4
AdvanSix Inc.
Condensed Consolidated Balance Sheets
(Unaudited)
(Dollars in thousands, except share and per share amounts)
| September 30, 2022 | December 31, 2021 | ||||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 24,694 | $ | 15,100 | |||||||
| Accounts and other receivables – net | 185,901 | 178,140 | |||||||||
| Inventories – net | 158,432 | 149,570 | |||||||||
| Taxes receivable | 14,930 | 947 | |||||||||
| Other current assets | 14,399 | 6,097 | |||||||||
| Total current assets | 398,356 | 349,854 | |||||||||
| Property, plant and equipment – net | 803,188 | 767,964 | |||||||||
| Operating lease right-of-use assets | 124,960 | 136,207 | |||||||||
| Goodwill | 56,192 | 17,592 | |||||||||
| Intangible assets | 50,004 | 17,980 | |||||||||
| Other assets | 22,833 | 22,402 | |||||||||
| Total assets | $ | 1,455,533 | $ | 1,311,999 | |||||||
| LIABILITIES | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 265,090 | $ | 211,511 | |||||||
| Accrued liabilities | 44,068 | 49,712 | |||||||||
| Income taxes payable | 24 | 9,723 | |||||||||
| Operating lease liabilities – short-term | 38,913 | 36,127 | |||||||||
| Deferred income and customer advances | 2,561 | 2,749 | |||||||||
| Total current liabilities | 350,656 | 309,822 | |||||||||
| Deferred income taxes | 152,412 | 133,330 | |||||||||
| Operating lease liabilities – long-term | 86,304 | 100,580 | |||||||||
| Line of credit – long-term | 135,000 | 135,000 | |||||||||
| Postretirement benefit obligations | 6,868 | 18,243 | |||||||||
| Other liabilities | 10,016 | 13,834 | |||||||||
| Total liabilities | 741,256 | 710,809 | |||||||||
| STOCKHOLDERS' EQUITY | |||||||||||
| Common stock, par value $0.01; 200,000,000 shares authorized; 31,962,466 shares issued and 27,715,594 outstanding at September 30, 2022; 31,755,430 shares issued and 28,139,954 outstanding at December 31, 2021 | 320 | 318 | |||||||||
| Preferred stock, par value $0.01; 50,000,000 shares authorized and 0 shares issued and outstanding at September 30, 2022 and December 31, 2021 | — | — | |||||||||
| Treasury stock at par (4,246,872 shares at September 30, 2022; 3,615,476 shares at December 31, 2021) | (42) | (36) | |||||||||
| Additional paid-in capital | 181,628 | 195,931 | |||||||||
| Retained earnings | 538,056 | 411,516 | |||||||||
| Accumulated other comprehensive loss | (5,685) | (6,539) | |||||||||
| Total stockholders' equity | 714,277 | 601,190 | |||||||||
| Total liabilities and stockholders' equity | $ | 1,455,533 | $ | 1,311,999 | |||||||
5
AdvanSix Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
(Dollars in thousands, except share and per share amounts)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
| Sales | $ | 478,769 | $ | 446,495 | $ | 1,541,578 | $ | 1,260,561 | |||||||||||||||
| Costs, expenses and other: | |||||||||||||||||||||||
| Costs of goods sold | 443,646 | 366,180 | 1,296,128 | 1,040,965 | |||||||||||||||||||
| Selling, general and administrative expenses | 23,069 | 21,121 | 65,120 | 62,112 | |||||||||||||||||||
| Interest expense, net | 686 | 1,174 | 2,017 | 4,096 | |||||||||||||||||||
| Other non-operating (income) expense, net | (1,394) | 331 | (1,825) | 349 | |||||||||||||||||||
| Total costs, expenses and other | 466,007 | 388,806 | 1,361,440 | 1,107,522 | |||||||||||||||||||
| Income before taxes | 12,762 | 57,689 | 180,138 | 153,039 | |||||||||||||||||||
| Income tax expense | 2,730 | 13,747 | 41,876 | 36,835 | |||||||||||||||||||
| Net income | $ | 10,032 | $ | 43,942 | $ | 138,262 | $ | 116,204 | |||||||||||||||
| Earnings per common share | |||||||||||||||||||||||
| Basic | $ | 0.36 | $ | 1.56 | $ | 4.92 | $ | 4.13 | |||||||||||||||
| Diluted | $ | 0.35 | $ | 1.51 | $ | 4.74 | $ | 4.02 | |||||||||||||||
| Weighted average common shares outstanding | |||||||||||||||||||||||
| Basic | 27,944,494 | 28,182,810 | 28,103,255 | 28,136,511 | |||||||||||||||||||
| Diluted | 28,889,658 | 29,100,276 | 29,173,537 | 28,920,832 | |||||||||||||||||||
6
AdvanSix Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(Dollars in thousands)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
| Cash flows from operating activities: | |||||||||||||||||||||||
| Net income | $ | 10,032 | $ | 43,942 | $ | 138,262 | $ | 116,204 | |||||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||||||||
| Depreciation and amortization | 17,644 | 16,325 | 51,870 | 49,058 | |||||||||||||||||||
| Loss on disposal of assets | 503 | 409 | 1,303 | 842 | |||||||||||||||||||
| Deferred income taxes | 6,138 | 3,423 | 8,696 | 11,235 | |||||||||||||||||||
| Stock-based compensation | 2,220 | 2,499 | 7,599 | 8,606 | |||||||||||||||||||
| Accretion of deferred financing fees | 155 | 142 | 464 | 424 | |||||||||||||||||||
| Changes in assets and liabilities, net of business acquisitions: | |||||||||||||||||||||||
| Accounts and other receivables | 59,491 | (5,575) | 7,346 | (46,549) | |||||||||||||||||||
| Inventories | (2,985) | (2,807) | 27 | 37,885 | |||||||||||||||||||
| Taxes receivable | (13,983) | 26 | (13,983) | 11,952 | |||||||||||||||||||
| Accounts payable | (18,662) | 20,226 | 43,468 | 27,047 | |||||||||||||||||||
| Income taxes payable | (8) | — | (9,699) | — | |||||||||||||||||||
| Accrued liabilities | 1,155 | 1,843 | (7,666) | 6,418 | |||||||||||||||||||
| Deferred income and customer advances | 954 | 188 | (188) | (23,241) | |||||||||||||||||||
| Other assets and liabilities | (3,720) | (4,153) | (23,512) | (14,358) | |||||||||||||||||||
| Net cash provided by operating activities | 58,934 | 76,488 | 203,987 | 185,523 | |||||||||||||||||||
| Cash flows from investing activities: | |||||||||||||||||||||||
| Expenditures for property, plant and equipment | (22,231) | (12,993) | (61,010) | (37,471) | |||||||||||||||||||
| Acquisition of business | — | — | (97,456) | (9,523) | |||||||||||||||||||
| Other investing activities | (366) | (493) | (1,587) | (975) | |||||||||||||||||||
| Net cash used for investing activities | (22,597) | (13,486) | (160,053) | (47,969) | |||||||||||||||||||
| Cash flows from financing activities: | |||||||||||||||||||||||
| Borrowings from line of credit | 123,500 | 29,000 | 354,000 | 133,500 | |||||||||||||||||||
| Payments of line of credit | (135,000) | (89,000) | (354,000) | (273,500) | |||||||||||||||||||
| Principal payments of finance leases | (231) | (170) | (712) | (534) | |||||||||||||||||||
| Dividend payments | (4,051) | — | (11,083) | — | |||||||||||||||||||
| Purchase of treasury stock | (13,172) | — | (23,591) | (589) | |||||||||||||||||||
| Issuance of common stock | 14 | 156 | 1,046 | 202 | |||||||||||||||||||
| Net cash used for financing activities | (28,940) | (60,014) | (34,340) | (140,921) | |||||||||||||||||||
| Net change in cash and cash equivalents | 7,397 | 2,988 | 9,594 | (3,367) | |||||||||||||||||||
| Cash and cash equivalents at beginning of period | 17,297 | 4,251 | 15,100 | 10,606 | |||||||||||||||||||
| Cash and cash equivalents at the end of period | $ | 24,694 | $ | 7,239 | $ | 24,694 | $ | 7,239 | |||||||||||||||
| Supplemental non-cash investing activities: | |||||||||||||||||||||||
| Capital expenditures included in accounts payable | $ | 19,182 | $ | 6,783 | |||||||||||||||||||
7
AdvanSix Inc.
Non-GAAP Measures
(Dollars in thousands, except share and per share amounts)
Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
| Net cash provided by operating activities | $ | 58,934 | $ | 76,488 | $ | 203,987 | $ | 185,523 | |||||||||||||||
| Expenditures for property, plant and equipment | (22,231) | (12,993) | (61,010) | (37,471) | |||||||||||||||||||
Free cash flow (1) | $ | 36,703 | $ | 63,495 | $ | 142,977 | $ | 148,052 | |||||||||||||||
(1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment | |||||||||||||||||||||||
The Company believes that this metric is useful to investors and management as a measure to evaluate our ability to generate cash flow from business operations and the impact that this cash flow has on our liquidity.
Reconciliation of Net Income to Adjusted EBITDA and Earnings Per Share to Adjusted Earnings Per Share
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
| Net income | $ | 10,032 | $ | 43,942 | $ | 138,262 | $ | 116,204 | |||||||||||||||
| Non-cash stock-based compensation | 2,220 | 2,499 | 7,599 | 8,606 | |||||||||||||||||||
| Non-recurring, unusual or extraordinary expenses | — | — | — | — | |||||||||||||||||||
| Non-cash amortization from acquisitions | 532 | 65 | 1,284 | 174 | |||||||||||||||||||
| One-time M&A costs | — | — | 277 | 172 | |||||||||||||||||||
| Benefit from income taxes relating to reconciling items | (466) | (391) | (1,461) | (1,378) | |||||||||||||||||||
| Adjusted Net Income | 12,318 | 46,115 | 145,961 | 123,778 | |||||||||||||||||||
| Interest expense, net | 686 | 1,174 | 2,017 | 4,096 | |||||||||||||||||||
| Income tax expense - adjusted | 3,196 | 14,138 | 43,337 | 38,213 | |||||||||||||||||||
| Depreciation and amortization - adjusted | 17,113 | 16,260 | 50,586 | 48,884 | |||||||||||||||||||
| Adjusted EBITDA | $ | 33,313 | $ | 77,687 | $ | 241,901 | $ | 214,971 | |||||||||||||||
| Sales | $ | 478,769 | $ | 446,495 | $ | 1,541,578 | $ | 1,260,561 | |||||||||||||||
Adjusted EBITDA Margin (2) | 7.0% | 17.4% | 15.7% | 17.1% | |||||||||||||||||||
(2) Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Sales | |||||||||||||||||||||||
8
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
| Net Income | $ | 10,032 | $ | 43,942 | $ | 138,262 | $ | 116,204 | |||||||||||||||
| Adjusted Net Income | 12,318 | 46,115 | 145,961 | 123,778 | |||||||||||||||||||
| Weighted-average number of common shares outstanding - basic | 27,944,494 | 28,182,810 | 28,103,255 | 28,136,511 | |||||||||||||||||||
| Dilutive effect of equity awards and other stock-based holdings | 945,164 | 917,466 | 1,070,282 | 784,321 | |||||||||||||||||||
| Weighted-average number of common shares outstanding - diluted | 28,889,658 | 29,100,276 | 29,173,537 | 28,920,832 | |||||||||||||||||||
| EPS - Basic | $ | 0.36 | $ | 1.56 | $ | 4.92 | $ | 4.13 | |||||||||||||||
| EPS - Diluted | $ | 0.35 | $ | 1.51 | $ | 4.74 | $ | 4.02 | |||||||||||||||
| Adjusted EPS - Basic | $ | 0.44 | $ | 1.64 | $ | 5.19 | $ | 4.40 | |||||||||||||||
| Adjusted EPS - Diluted | $ | 0.43 | $ | 1.58 | $ | 5.00 | $ | 4.28 | |||||||||||||||
The Company believes the non-GAAP financial measures presented in this release provide meaningful supplemental information as they are used by the Company’s management to evaluate the Company’s operating performance, enhance a reader’s understanding of the financial performance of the Company, and facilitate a better comparison among fiscal periods and performance relative to its competitors, as these non-GAAP measures exclude items that are not considered core to the Company’s operations.
9
AdvanSix Inc.
Appendix
(Pre-tax income impact, Dollars in millions)
Planned Plant Turnaround Schedule (3)
| 1Q | 2Q | 3Q | 4Q | FY | |||||||||||||
| 2017 | — | ~$10 | ~$4 | ~$20 | ~$34 | ||||||||||||
| 2018 | ~$2 | ~$10 | ~$30 | — | ~$42 | ||||||||||||
| 2019 | — | ~$5 | ~$5 | ~$25 | ~$35 | ||||||||||||
| 2020 | ~$2 | ~$7 | ~$20 | ~$2 | ~$31 | ||||||||||||
| 2021 | ~$3 | ~$8 | — | ~$18 | ~$29 | ||||||||||||
| 2022 | ~$1 | ~$5 | ~$44 | — | ~$50 | ||||||||||||
| 2023E | ~$3 | — | $25-$30 | — | $28-$33 | ||||||||||||
(3) Primarily reflects the impact of fixed cost absorption, maintenance expense, and the purchase of feedstocks which are normally manufactured by the Company.
10